| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.14.5.746 |
| P698 | PubMed publication ID | 8172852 |
| P2093 | author name string | K Okumura | |
| T Ito | |||
| K Shimizu | |||
| M Muramatsu | |||
| H Hashimoto | |||
| K Naruse | |||
| Y Miyazaki | |||
| Y Toki | |||
| P433 | issue | 5 | |
| P304 | page(s) | 746-752 | |
| P577 | publication date | 1994-05-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. PGH2 does not contribute to impaired endothelium-dependent relaxation | |
| P478 | volume | 14 |
| Q44677251 | An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes |
| Q49824930 | Anti inflammatory effect of asiaticoside on human umbilical vein endothelial cells induced by ox-LDL. |
| Q83303992 | Atheroprotective effects of dietary L-arginine increase with age in cholesterol-fed rabbits |
| Q36313684 | Atherosclerosis: from biology to pharmacological treatment |
| Q62031874 | Blueberry intervention improves vascular reactivity and lowers blood pressure in high-fat-, high-cholesterol-fed rats |
| Q34006311 | Cell signaling by reactive nitrogen and oxygen species in atherosclerosis |
| Q37591188 | Characterization of a fluorescent probe for imaging nitric oxide. |
| Q36354759 | Cytochrome P450 1B1 Contributes to the Development of Atherosclerosis and Hypertension in Apolipoprotein E-Deficient Mice |
| Q63184881 | Dietary l-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbits |
| Q40817829 | Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl cysteine |
| Q74464707 | Distribution and prevalence of inducible nitric oxide synthase in atherosclerotic vessels of long-term cholesterol-fed rabbits |
| Q34964020 | Effect of estrogen on endothelial function and angiogenesis |
| Q41120249 | Effects of nitric oxide on cholesterol metabolism in macrophages |
| Q73137299 | Endogenous nitric oxide release modulates mural platelet thrombosis and neutrophil-endothelium interactions under low and high shear conditions |
| Q33815804 | Endothelial nitric oxide in humans in health and disease. |
| Q35058386 | Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis |
| Q28584822 | Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice |
| Q38658248 | Endothelium-Derived Nitric Oxide as an Antiatherogenic Mechanism: Implications for Therapy |
| Q34693858 | Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene |
| Q40923166 | Gene transfer of nitric oxide synthase: effects on endothelial biology |
| Q74567630 | Hypocholesterolemic properties of nitric oxide. In vivo and in vitro studies using nitric oxide donors |
| Q37053935 | Impaired blood rheology is associated with endothelial dysfunction in patients with coronary risk factors |
| Q41669059 | Impaired endothelial function in patients with nephrotic range proteinuria |
| Q44555808 | Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease |
| Q47822939 | Inducible nitric oxide synthase and atherosclerosis. |
| Q34792996 | Influence of chronic treatment with a nitric oxide donor on fatty streak development and reactivity of the rabbit aorta |
| Q40865183 | Inhibition of inducible nitric oxide synthesis by oxidized lipoprotein(a) in a murine macrophage cell line. |
| Q41822901 | Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats |
| Q50957789 | Insulin Resistance, Obesity and Lipotoxicity. |
| Q33880303 | Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009 |
| Q77298771 | Is smooth muscle growth in primate arteries regulated by endothelial nitric oxide synthase? |
| Q40958378 | Lipid hydroperoxides inhibit nitric oxide production in RAW264.7 macrophages |
| Q35799761 | Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis. |
| Q56944425 | Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented model |
| Q48019037 | Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts |
| Q78257065 | Membrane stabilization in harvested vein graft storage: effects on adhesion molecule expression and nitric oxide synthesis |
| Q34772312 | Modulating role of estradiol on arginase II expression in hyperlipidemic rabbits as an atheroprotective mechanism |
| Q40923118 | New approaches to the prevention of atherosclerosis |
| Q34209867 | Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis |
| Q33701403 | Nitric oxide and arginine |
| Q41335841 | Nitric oxide and atherosclerosis: possible implications for therapy |
| Q57791197 | Nitric oxide and hypercholesterolemia: a matter of oxidation and reduction? |
| Q33631353 | Nitric oxide and lipid peroxidation |
| Q40467964 | Nitric oxide and oxygen radicals: a question of balance |
| Q24645400 | Nitric oxide and peroxynitrite in health and disease |
| Q34105472 | Nitric oxide and postangioplasty restenosis: pathological correlates and therapeutic potential |
| Q72114146 | Nitric oxide donor compounds inhibit the toxicity of oxidized low‐density lipoprotein to endothelial cells |
| Q36628207 | Nitric oxide function in atherosclerosis |
| Q42009952 | Nitric oxide in the human cardiovascular system--SKB lecture 1997. |
| Q99731203 | Nitric oxide synthase inhibition with N(G)-monomethyl-L-arginine: determining the window of effect in the human vasculature |
| Q43545481 | Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice. |
| Q77718621 | Oral administration of NO synthase inhibitor failed to promote arteriosclerotic lesions in the aorta and the coronary arteries of rabbits fed cholesterol |
| Q33610044 | Pathophysiology of nitric oxide and related species: free radical reactions and modification of biomolecules |
| Q34189108 | Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. |
| Q73271039 | Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity |
| Q35105487 | Regulation of cell signalling by vitamin E |
| Q39795620 | Role of nitric oxide in experimental obliterative bronchiolitis (chronic rejection) in the rat. |
| Q74611649 | Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: effects on neointimal hyperplasia and vascular remodeling |
| Q37371073 | Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits |
| Q44146848 | The Glu298Asp polymorphism in endothelial nitric oxide synthase gene is associated with coronary in-stent restenosis |
| Q34604584 | The mechanism of action of antioxidants against lipoprotein peroxidation, evaluation based on kinetic experiments |
| Q40418229 | The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease |
| Q74070194 | Vascular endothelial growth factor-induced angiogenesis: crouching tiger or hidden dragon? |
| Q73998825 | [Myocardial perfusion reserve studied by single-photon emission-computed tomography with thallium-201 and a drug stress test with adenosine triphosphate in patients with cardiovascular risk factors] |
Search more.